How to use Gaviscon duo tab o smaku miemti
Contents of the leaflet
- Leaflet attached to the packaging: patient information
- Gaviscon duo tab mint flavor
- 250 mg + 106.5 mg + 187.5 mg, chewable tablets
- What is Gaviscon duo tab mint flavor and what is it used for
- Important information before using Gaviscon duo tab mint flavor
- When not to use this medicine
- Warnings and precautions
- Before taking Gaviscon duo tab mint flavor, the patient should discuss it with their doctor or pharmacist:
- If symptoms persist for more than 7 days, the patient should consult their doctor.
- Children
- This medicine should not be given to children under 12 years of age. There is a risk of increased sodium levels in the blood (hypernatremia) in children with kidney function disorders or stomach and intestinal inflammation.
- Gaviscon duo tab mint flavor and other medicines
- Pregnancy, breastfeeding, and fertility
- Important information about some ingredients of this medicine
- How to use Gaviscon duo tab mint flavor
- Possible side effects
- How to store Gaviscon duo tab mint flavor
- Package contents and other information
- What Gaviscon duo tab mint flavor contains
- What Gaviscon duo tab mint flavor looks like and what the package contains
- Marketing authorization holder and manufacturer
- Marketing authorization holder:
- Manufacturer/Importer:
- This medicine is authorized in the Member States of the European Economic Area under the following names:
- Date of last revision of the leaflet: 12/2024
Leaflet attached to the packaging: patient information
Gaviscon duo tab mint flavor
250 mg + 106.5 mg + 187.5 mg, chewable tablets
Sodium alginate + Sodium hydrogen carbonate + Calcium carbonate
Read the leaflet carefully before taking the medicine, as it contains important information for the patient.
Read the leaflet carefully before using the medicine, as it contains important information for the patient.
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
- Keep this leaflet, you may need to read it again.
- If you need advice or additional information, consult a pharmacist.
- If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist. See section 4.
- If after 7 days there is no improvement or the patient feels worse, they should contact their doctor.
Table of contents of the leaflet:
- 1. What is Gaviscon duo tab mint flavor and what is it used for
- 2. Important information before using Gaviscon duo tab mint flavor
- 3. How to use Gaviscon duo tab mint flavor
- 4. Possible side effects
- 5. How to store Gaviscon duo tab mint flavor
- 6. Package contents and other information
1. What is Gaviscon duo tab mint flavor and what is it used for
Gaviscon duo tab mint flavor is a combination of alginate and two acid-neutralizing agents (calcium carbonate and sodium hydrogen carbonate) that work in two ways:
- 1. Creating a protective barrier over the stomach contents, which helps to relieve heartburn (the soothing effect can last up to 4 hours).
- 2. Neutralizing excess stomach acid to relieve pain and discomfort.
This medicine is used to treat symptoms of acid reflux, such as heartburn, acid regurgitation, and indigestion, for example after meals or during pregnancy.
2. Important information before using Gaviscon duo tab mint flavor
When not to use this medicine
- if the patient is allergic to the active substances or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Before taking Gaviscon duo tab mint flavor, the patient should discuss it with their doctor or pharmacist:
- if the patient has or has had a serious kidney or heart disease, as some salts may affect these diseases (the patient should discuss the salt content of the medicine with their doctor).
- if the patient has previously been diagnosed with intolerance to some sugars.
- if the patient has severe kidney impairment.
- if the patient has electrolyte disturbances causing low phosphate levelsin the blood (hypophosphatemia).
- If the patient has reduced stomach acid, the medicine may be less effective.
Like other acid-neutralizing medicines, taking this medicine may mask the symptoms of other, more serious diseases.
If symptoms persist for more than 7 days, the patient should consult their doctor.
Children
This medicine should not be given to children under 12 years of age. There is a risk of increased sodium levels in the blood (hypernatremia) in children with kidney function disorders or stomach and intestinal inflammation.
Gaviscon duo tab mint flavor and other medicines
The patient should not take this medicine within 2 hours of taking other oral medicines, as it may interfere with their action. This is especially important if the patient is taking antihistamines, antibiotics (tetracyclines and quinolones, such as norfloxacin), iron preparations, thyroid hormones, antifungal medicines (such as ketoconazole), digoxin, and beta-adrenolytics (used in heart diseases), neuroleptics (used in mental illnesses), thyroxine, chloroquine (used in malaria), bisphosphonates (used in osteoporosis), and estramustine (used in prostate cancer). The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Pregnancy, breastfeeding, and fertility
The patient can take this medicine if they are pregnant, breastfeeding, or planning to have a child. As with all medicines, the duration of treatment should be as short as possible.
Important information about some ingredients of this medicine
This medicine contains 5.86 mg of aspartame (E951) in each chewable tablet. Aspartame is a source of phenylalanine. It may be harmful if the patient has phenylketonuria, a rare genetic disorder in which phenylalanine accumulates, as the body cannot remove it properly. The chewable tablets contain azorubine (E122), which may cause an allergic reaction. The medicine contains 223.7 mg (9.728 mmol) of sodium in a dose of four chewable tablets. The maximum recommended daily dose of this medicine contains 895 mg of sodium (found in salt). This corresponds to 44.75% of the recommended maximum daily sodium intake for an adult. If the patient takes this medicine daily for a long time, they should talk to their pharmacist or doctor, especially if they have been advised to follow a low-sodium diet. The medicine contains 300 mg (7.5 mmol) of calcium in a dose of four chewable tablets. Before taking this medicine, the patient should talk to their doctor if they have kidney stones or high calcium levels in the blood. If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking this medicine.
3. How to use Gaviscon duo tab mint flavor
This medicine should always be used exactly as described in this patient leaflet or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist. Oral administration. Chew thoroughly before swallowing. Adults and adolescents over 12 years:If symptoms occur, take 2 to 4 chewable tablets after meals and before bedtime, up to 4 times a day. Children under 12 years:Not recommended for children under 12 years.
Taking a higher dose of this medicine than recommended
It is unlikely that taking too much of this medicine will harm the patient. However, they may experience bloating and abdominal discomfort. If the symptoms do not go away, the patient should consult their doctor. Missing a dose of this medicine:The patient should not take a double dose to make up for a missed dose. They should continue taking the medicine as before.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. If the patient experiences side effects, they should stop taking the medicine and consult their doctor immediately. Very rarely (may affect up to 1 in 10,000 people), an allergic reaction to the ingredients of the medicine may occur. Symptoms may include abdominal pain, diarrhea, nausea, vomiting, rash, itching, dizziness, facial swelling, lip swelling, tongue swelling, or throat swelling, and difficulty breathing. Taking large amounts of calcium carbonate, an ingredient of this medicine, may cause elevated blood pH (alkalosis), high calcium levels in the blood (hypercalcemia), increased stomach acid production, and constipation. These usually occur after taking higher than recommended doses.
Reporting side effects
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be collected on the safety of the medicine.
5. How to store Gaviscon duo tab mint flavor
The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the carton and blister after "EXP". The expiry date refers to the last day of the month stated. Do not store above 30°C. Store in the original package to protect from moisture. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
6. Package contents and other information
What Gaviscon duo tab mint flavor contains
The active substances in each chewable tablet are 250 mg of sodium alginate, 106.5 mg of sodium hydrogen carbonate, and 187.5 mg of calcium carbonate. The other ingredients are: macrogol 20, mannitol type 100, copovidone, peppermint flavor (containing sucrose, maltodextrin, and gum arabic), acesulfame potassium, aspartame (E951), azorubine, aluminum lake (E122), magnesium stearate, xylitol.
What Gaviscon duo tab mint flavor looks like and what the package contains
Flat, round, two-layer chewable tablets with a mint flavor and smell. One layer of the chewable tablet is pink and has a slightly speckled appearance with GDA markings on the surface, and the other layer is white with sword and circle markings. This medicine is available in packages containing 12, 16, 24, 32, 48, 60 chewable tablets. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Reckitt Benckiser (Poland) S.A., ul. Okunin 1, 05-100 Nowy Dwór Mazowiecki, tel. 0 801 88 88 07
Manufacturer/Importer:
RB NL Brands B.V., Schiphol Boulevard 207, 1118 BH Schiphol, Netherlands
This medicine is authorized in the Member States of the European Economic Area under the following names:
| Austria | GAVISCON DUAL Mintgeschmack 250 mg/106,5 mg/187,5 mg Kautabletten |
| Bulgaria | Gaviscon Double Action Peppermint chewable tablets |
| Denmark | Galieve Extra Peppermint |
| Estonia | Gaviscon |
| Finland | Galieve Dual Peppermint |
| France | Gaviscon Antiacide – Antireflux MENTHE SANS SUCRE, comprimé à croquer édulcoré à l'aspartam et à l'acésulfame potassique |
| Netherlands | Gaviscon Duo muntsmaak 250 mg /106,5 mg/187,5 mg, kauwtabletten |
| Iceland | Galieve Forte piparmyntu tuggutöflur |
| Lithuania | Gaviscon 250 mg/106,5 mg/187,5 mg kramtomosios tabletės |
| Latvia | Gaviscon 250 mg/106,5 mg/187,5 mg košļājamās tabletes |
| Norway | Galieve Forte |
| Poland | Gaviscon duo tab o smaku mięty |
| Portugal | Gaviscon Duefet |
| Romania | Gaviscon Forte Mentol comprimate masticabile |
| Hungary | GAVISCON FORTE borsmenta ízű rágótabletta |
Date of last revision of the leaflet: 12/2024

- Country of registration
- Dosage formTablets, 250 mg + 106.5 mg + 187.5 mg
- ATC codeA02BX13
- Active substance
- Prescription requiredNo
- Manufacturer
- ImporterRB NL Brands B.V
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to Gaviscon duo tab o smaku miemtiDosage form: Suspension, 500 mg + 213 mg + 325 mgActive substance: alginic acidPrescription not requiredDosage form: Suspension, 500 mg + 213 mg + 325 mgActive substance: alginic acidPrescription not requiredDosage form: Tablets, 250 mg + 106.5 mg + 187.5 mgActive substance: alginic acidManufacturer: RB NL Brands B.V.Prescription not required
Online doctors for Gaviscon duo tab o smaku miemti
Discuss questions about Gaviscon duo tab o smaku miemti, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Get Gaviscon duo tab o smaku miemti Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
Gaviscon duo tab o smaku miemti does not require a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in Gaviscon duo tab o smaku miemti is alginic acid. This information helps identify medicines with the same composition but different brand names.
Gaviscon duo tab o smaku miemti is manufactured by RB NL Brands B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Gaviscon duo tab o smaku miemti is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy Gaviscon duo tab o smaku miemti in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
Other medicines with the same active substance (alginic acid) include Gaviscon duo o smaku miemti, Gaviscon duo o smaku ovocuv leshnih, Gaviscon duo tab o smaku ovocuv leshnih. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
















